TipRanks
Go Ultimate55% OFF

Sika (SIKB) Stock Price & Analysis

SIKB Stock Chart & Stats

€19.00€0.20(1.06%)
At close: 1:00 AM GMT+1
€18€20€2223 Jul10 Aug26 Aug29 Sep30 Sep15 Oct
Day’s Range
EUR 19.00 - EUR 19.00
52-Week Range
EUR 13.50 - EUR 21.80
Previous Close
EUR 18.80
Volume
N/A
Average Volume (3M)
85
Market Cap
EUR 31.19B
Enterprise Value
EUR 39.97B
Total Cash (Recent Filing)
EUR 623.09M
Total Debt (Recent Filing)
EUR 6.03B
Price to Earnings (P/E)
27.6
Beta
1.17
Next Earnings
Feb 19, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
1.30%

Bulls Say, Bears Say

Bulls Say

Durable Profitability

Sika maintains strong underlying profitability for a specialty chemicals business, supported by steady gross margins and mid-teens EBIT margins. This indicates meaningful value capture from differentiated products and systems, providing a durable base for reinvestment and earnings resilience.

Positive Free Cash Flow

High conversion of earnings into free cash flow demonstrates that reported profitability is supported by cash generation. Positive free cash flow growth also gives Sika capacity to fund operations, investment, and shareholder returns while retaining flexibility through changing market conditions.

Value-Added, Diversified Model

Sika's broad portfolio spans construction and industrial applications, while technical services and project-specified systems support differentiated, value-added sales. Exposure to refurbishment and maintenance adds recurring demand alongside new construction, strengthening business durability across cycles.

Bears Say

Revenue And Margin Contraction

The 2025 revenue decline and lower net margin show that recent operating momentum has weakened after several years of expansion. If softness persists, reduced scale and profitability could constrain reinvestment, limit earnings growth, and weaken the company's ability to absorb cost pressure.

Softening Operating Cash Conversion

Although free cash flow remains positive, weaker operating cash flow relative to sales indicates less efficient conversion of revenue into cash. Sustained deterioration could increase reliance on external funding or working-capital management and reduce flexibility for investment and capital allocation.

Moderate Leverage And Lower Returns

Sika's balance sheet is described as generally sound, but meaningful leverage reduces financial flexibility compared with a lightly indebted structure. The decline in return on equity also signals weaker capital productivity, which may weigh on future compounding if operating performance remains subdued.

Sika News

SIKB FAQ

What was Sika’s price range in the past 12 months?
Sika lowest stock price was €13.50 and its highest was €21.80 in the past 12 months.
What is Sika’s market cap?
Sika’s market cap is €31.19B.
When is Sika’s upcoming earnings report date?
Sika’s next earnings report is estimated for Feb 19, 2027 (not yet confirmed), which is in 108 days.
How were Sika’s earnings last quarter?
Sika released its earnings results on Jul 29, 2026. The company reported €0.374 earnings per share for the quarter, missing the consensus estimate of €0.376 by -€0.002.
Is Sika overvalued?
According to Wall Street analysts Sika’s price is currently Undervalued.
Does Sika pay dividends?
Sika does not currently pay dividends.
What is Sika’s EPS estimate?
Sika’s EPS estimate is 0.43.
How many shares outstanding does Sika have?
Sika has 1,604,793,000 shares outstanding.
What happened to Sika’s price movement after its last earnings report?
Sika reported an EPS of €0.374 in its last earnings report, missing expectations of €0.376. Following the earnings report the stock price went up 9.357%.
Which hedge fund is a major shareholder of Sika?
Currently, no hedge funds are holding shares in DE:SIKB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology